These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6153783)

  • 1. Influence of dimercaprol (2,3-dimercapto-1-propanol) on the pharmacokinetics of 111In-bleomycin in the P-1798 lymphoma-bearing BALB/c mouse.
    Sartiano GP; Levine G; Boggs SS
    Oncology; 1980; 37(2):120-4. PubMed ID: 6153783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dimercaprol on the early hepatic uptake of 111In-bleomycin in the BALB/c mouse.
    Levine G; Sartiano GP; Boggs SS; Fried A; Gumerman LW
    J Nucl Med; 1976 Dec; 17(12):1083-7. PubMed ID: 62831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
    Konikowski T; Haynie TP; Glenn HJ
    J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga-citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice.
    DeNardo GL; Krohn KA; DeNardo SJ
    Cancer; 1977 Dec; 40(6):2923-9. PubMed ID: 73412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111-In-bleomycin kinetics in mice bearing transplantable tumors of lung, skin, and bone.
    Robbins PJ; Silberstein EB; Fortman DL
    J Nucl Med; 1974 Apr; 15(4):273-8. PubMed ID: 4131859
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of I-bleomycin prepared by two methods stability and pharmacokinetics in tumor-bearing mice.
    Krohn KA; Meyers J; DeNardo GL
    Radiology; 1977 Jan; 122(1):179-82. PubMed ID: 63131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of labeled bleomycin in normal and tumor-bearing mice.
    Grove RB; Eckelman WC; Reba RC
    J Nucl Med; 1973 Dec; 14(12):917-9. PubMed ID: 4127738
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Int J Nucl Med Biol; 1984; 11(2):129-39. PubMed ID: 6207129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of bleomycin after im administration in man.
    Oken MM; Crooke ST; Elson MK; Strong JE; Shafer RB
    Cancer Treat Rep; 1981; 65(5-6):485-9. PubMed ID: 6165473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
    Blottner A; Deckart H; Weiland J
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    J Surg Oncol; 1985 Jun; 29(2):71-7. PubMed ID: 2417054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new tumor imaging agent--111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor-bearing animals.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Miller EE; Larson SM
    J Surg Oncol; 1984 Nov; 27(3):189-95. PubMed ID: 6208427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of 111In-bleomycin in vivo--properties compared with 57Co-bleomycin.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Farkas RJ; Miller EE
    Eur J Nucl Med; 1983; 8(12):535-40. PubMed ID: 6199207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies.
    Gabizon A; Price DC; Huberty J; Bresalier RS; Papahadjopoulos D
    Cancer Res; 1990 Oct; 50(19):6371-8. PubMed ID: 1698120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new 111In-bleomycin complex for combined radiotherapy and chemotherapy.
    Hou DY; Hoch H; Johnston GS; Tsou KC; Jones AE; Farkas RJ; Miller EE; Larson SM
    J Surg Oncol; 1985 Jun; 29(2):91-8. PubMed ID: 2417055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution studies of 111In labeled bleomycin in the intratumoral and peritumoral treatment of advanced squamous cell carcinomas in the oto-rhino-larygnological region (author's transl)].
    Glasowski P; Zambelis N
    Laryngol Rhinol Otol (Stuttg); 1978 May; 57(5):472-4. PubMed ID: 77462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma].
    Petriev VM; Vatin AE; Prusova RM; Filatov PP; Khachirov DG
    Antibiotiki; 1982 Aug; 27(8):623-6. PubMed ID: 6181732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.